Literature DB >> 23339204

MRI findings in a cohort of brain injured survivors of pediatric cerebral malaria.

Sam D Kampondeni1, Michael J Potchen, Nicholas A V Beare, Karl B Seydel, Simon J Glover, Terrie E Taylor, Gretchen L Birbeck.   

Abstract

Abstract. A prospective cohort study of retinopathy-confirmed cerebral malaria (CM) survivors identified 42 of 132 with neurologic sequelae. The 38 survivors with sequelae who were alive when magnetic resonance imaging (MRI) technology became available underwent brain MRIs. Common MRI abnormalities included periventricular T2 signal changes (53%), atrophy (47%), subcortical T2 signal changes (18%), and focal cortical defects (16%). The χ(2) tests assessed the relationship between chronic MRI findings, acute clinical and demographic data, and outcomes. Children who were older at the time of CM infection (P = 0.01) and those with isolated behavioral problems (P = 0.02) were more likely to have a normal MRI. Acute focal seizures were associated with atrophy (P = 0.05). Acute papilledema was associated with subcortical T2 signal changes (P = 0.02). Peripheral retinal whitening (P = 0.007) and a higher admission white blood cell count (P = 0.02) were associated with periventricular T2 signal changes. Chronic MRI findings suggest seizures, increased intracranial pressure, and microvascular ischemia contribute to clinically relevant structural brain injury in CM.

Entities:  

Mesh:

Year:  2013        PMID: 23339204      PMCID: PMC3592538          DOI: 10.4269/ajtmh.12-0538

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Perfusion abnormalities in children with cerebral malaria and malarial retinopathy.

Authors:  Nicholas A V Beare; Simon P Harding; Terrie E Taylor; Susan Lewallen; Malcolm E Molyneux
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

Review 2.  NeuroInterp: a method for facilitating neuroimaging research on cerebral malaria.

Authors:  Michael J Potchen; Sam D Kampondeni; Khalid Ibrahim; Joseph Bonner; Karl B Seydel; Terrie E Taylor; Gretchen L Birbeck
Journal:  Neurology       Date:  2013-08-06       Impact factor: 9.910

Review 3.  Pathogenesis, clinical features, and neurological outcome of cerebral malaria.

Authors:  Richard Idro; Neil E Jenkins; Charles R J C Newton
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

4.  Electroencephalographic and clinical features of cerebral malaria.

Authors:  J Crawley; S Smith; P Muthinji; K Marsh; F Kirkham
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

5.  Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease.

Authors:  M J Potchen; S D Kampondeni; K B Seydel; G L Birbeck; C A Hammond; W G Bradley; J K DeMarco; S J Glover; J O Ugorji; M T Latourette; J E Siebert; M E Molyneux; T E Taylor
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-19       Impact factor: 3.825

6.  Axonal injury in cerebral malaria.

Authors:  Isabelle M Medana; Nicholas P Day; Tran Tinh Hien; Nguyen Thi Hoang Mai; Delia Bethell; Nguyen Hoan Phu; Jeremy Farrar; Margaret M Esiri; Nicholas J White; Gareth D Turner
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Seizures and status epilepticus in childhood cerebral malaria.

Authors:  J Crawley; S Smith; F Kirkham; P Muthinji; C Waruiru; K Marsh
Journal:  QJM       Date:  1996-08

8.  Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study.

Authors:  Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor
Journal:  Lancet Neurol       Date:  2010-11-04       Impact factor: 44.182

9.  Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

Authors:  Terrie E Taylor; Wenjiang J Fu; Richard A Carr; Richard O Whitten; Jeffrey S Mueller; Nedson G Fosiko; Susan Lewallen; N George Liomba; Malcolm E Molyneux; Jeffrey G Mueller
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

10.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

  10 in total
  15 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Diffusion-Weighted MR Imaging in a Prospective Cohort of Children with Cerebral Malaria Offers Insights into Pathophysiology and Prognosis.

Authors:  S M Moghaddam; G L Birbeck; T E Taylor; K B Seydel; S D Kampondeni; M J Potchen
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-22       Impact factor: 3.825

3.  Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria.

Authors:  Fatima El-Assaad; Valery Combes; Georges Er Grau
Journal:  J Neuroinfect Dis       Date:  2014-01-06

4.  PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.

Authors:  Lena Serghides; Chloe R McDonald; Ziyue Lu; Miriam Friedel; Cheryl Cui; Keith T Ho; Howard T J Mount; John G Sled; Kevin C Kain
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

5.  Transient lesion in the splenium of the corpus callosum in acute uncomplicated falciparum malaria.

Authors:  Jiraporn Laothamatas; Christina L Sammet; Xavier Golay; Marc Van Cauteren; Varinee Lekprasert; Noppadon Tangpukdee; Srivicha Krudsood; Wattana Leowattana; Polrat Wilairatana; Srirama V Swaminathan; Robert L DeLaPaz; Truman R Brown; Sornchai Looareesuwan; Gary M Brittenham
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

6.  Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.

Authors:  Adéla Nacer; Alexandru Movila; Fabien Sohet; Natasha M Girgis; Uma Mahesh Gundra; P'ng Loke; Richard Daneman; Ute Frevert
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

Review 7.  Vascular dysfunction as a target for adjuvant therapy in cerebral malaria.

Authors:  Leonardo José de Moura Carvalho; Aline da Silva Moreira; Cláudio Tadeu Daniel-Ribeiro; Yuri Chaves Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

Review 8.  Fatal cerebral malaria: a venous efflux problem.

Authors:  Ute Frevert; Adéla Nacer
Journal:  Front Cell Infect Microbiol       Date:  2014-11-06       Impact factor: 5.293

9.  Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?

Authors:  Manuela Polimeni; Mauro Prato
Journal:  Fluids Barriers CNS       Date:  2014-01-27

10.  The systemic pathology of cerebral malaria in African children.

Authors:  Danny A Milner; Richard O Whitten; Steve Kamiza; Richard Carr; George Liomba; Charles Dzamalala; Karl B Seydel; Malcolm E Molyneux; Terrie E Taylor
Journal:  Front Cell Infect Microbiol       Date:  2014-08-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.